Researchers analyzed concentrations of microplastics in 91 brain tissue samples collected during autopsies in 2016 and 2024. The samples were from the frontal cortex, the brain region above and behind ...

Nonincretin revenue climbed 20% year-over-year fueled by diabetes drug Jardiance ($1.2 billion with 50% growth) and breast cancer therapy Verzenio ($1.6 billion with 36% growth). However Type 2 ...

and sales of diabetes drug Jardiance increased 50% to $1.19 billion. Zepbound sales reached $1.91 billion, up from $175.8 million a year ago. Trulicity sales fell 25% to $1.25 billion. Guidance ...

Growth Products revenue increased 13% to $5.95 billion, driven by growth in Verzenio and Jardiance, partially offset by lower Trulicity sales. Also Read: FDA Approves Expanded Use Of Eli Lilly’s ...

Nonincretin revenue climbed 20% year-over-year fueled by diabetes drug Jardiance ($1.2 billion with 50% growth) and breast cancer therapy Verzenio ($1.6 billion with 36% growth). However Type 2 ...

The EMPACT-MI trial found that giving Boehringer Ingelheim and Eli Lilly’s SGLT2 drug Jardiance (empagliflozin ... a subsequent cardiovascular event by 10% compared to placebo, but that wasn ...

The new approval comes shortly after Jardiance became the first SGLT2 drug to be approved by the FDA in children 10 years and older with type 2 diabetes. At JPM Week 2025 in San Francisco ...

Generic Eng Standalone December 2023 Net Sales at Rs 58.97 crore, down 5.09% Y-o-Y Mar 01 2024 01:54 PM Generic Eng Standalone September 2023 Net Sales at Rs 37.20 crore, down 30.48% Y-o-Y Dec 04 ...